The Role of Immunohistochemical Biomarkers as Prognostic Factorsby the Use of a Tissue Microarray in Breast Cancer PatientsUnder 45-years-old.
10.3857/jkstro.2008.26.1.45
- Author:
Eun Seog KIM
1
;
Doo Ho CHOI
;
So Young JIN
;
Dong Wha LEE
;
Hee Sook PARK
;
Min Hyuk LEE
;
Jong Ho WON
;
Yong Ho KIM
;
Kyu Taek LEE
;
Sung Yong KIM
Author Information
1. Department of Radiation Oncology, Soonchunhyang University School of Medicine, Seoul, Korea. dohochoi@hanmail.net
- Publication Type:Original Article
- Keywords:
Breast cancer;
Tissue microarray;
Biomarkers
- MeSH:
Female;
Humans;
Neoplasm Metastasis;
Breast Neoplasms
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology
2008;26(1):45-55
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study evaluates the association of estrogen receptor (ER), progesterone receptor (PR), Her-2, COX-2, and survivin with the clinicopathological features and outcomes in young Korean women with breast cancer using recently developed tissue microarray (TMA) technology. MATERIALS AND METHODS: A cohort of 212 young patients with breast cancer diagnosed at the age of 45 years or younger from March 1994 to August 2005, were enrolled in this study. The age range of patients was 23~45 years (median age, 39 years). The minimum and median follow-up periods were 24 months and 60 months, respectively. Serial sections of primary tumors were processed by the use of a TMA for immunohistochemical staining for five biomarkers. The correlation of these five biomarkers and the clinicopathological features and outcomes were analyzed by statistical methods. RESULTS: The majority of the patients were stage T1 (90 patients) or T2 (101 patients), and 105 patients (49.5%) had an axillary node metastasis. The 5-year overall and relapse free survival rates for all of the patients were 90.4% and 82.3%, respectively, and 36 patients had a locoregional or distant metastasis as a first event. Positive expression of ER, PR, Her-2, COX-2, and survivin was determined in 38.2%, 45.3%, 25.9%, 41.5%, and 43.4%, of the tumor samples, respectively. Tumor stage, nodal status, age, as well as expression of ER, PR, and HER-2 status were significantly associated with the disease free survival rate. Tumor stage, nodal status, as well as expression of ER, PR, and HER-2 were significantly related with the overall survival rate. Expression of COX-2 and survivin were not single independent prognostic factors for the disease free and overall survival rate although co-expression of HER-2 and COX-2 had a tendency as a poor prognostic factor. By multivariate analysis, only T stage and lymph node status were significant prognostic factors, and ER status was a marginally significant prognostic factor (p=0.075). CONCLUSION: Expression of ER, PR and HER-2 were significant prognostic factors for the relapse free and overall survival rate. Expression of COX-2 and survivin were not prognostic factors for young women with breast cancer.
